These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 29493100

  • 1. Glucose excursions and hypoglycemia in patients with type 2 diabetes treated with mitiglinide/voglibose versus glimepiride: A randomized cross-over trial.
    Fujimoto K, Shibayama Y, Yamaguchi E, Honjo S, Hamasaki A, Hamamoto Y.
    J Diabetes; 2018 Aug; 10(8):675-682. PubMed ID: 29493100
    [Abstract] [Full Text] [Related]

  • 2. Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial.
    Tanaka K, Okada Y, Umezu S, Hashimoto R, Tomoyose Y, Tateyama R, Hori Y, Saito M, Tokutsu A, Sonoda S, Uemura F, Kurozumi A, Tanaka Y.
    J Diabetes Investig; 2024 Apr; 15(4):449-458. PubMed ID: 38149694
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mitiglinide/voglibose fixed-dose combination improves postprandial glycemic excursions in Japanese patients with type 2 diabetes mellitus.
    Ono Y, Kameda H, Cho KY.
    Expert Opin Pharmacother; 2013 Mar; 14(4):361-70. PubMed ID: 23414242
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the Efficacy of Repaglinide Versus the Combination of Mitiglinide and Voglibose on Glycemic Variability in Japanese Patients with Type 2 Diabetes.
    Okada H, Tanaka M, Hasegawa G, Nakajima H, Kadono M, Okada Y, Hirata A, Oyamada H, Yamane T, Fukui M.
    Curr Pharm Des; 2020 Mar; 25(43):4600-4605. PubMed ID: 31538887
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus.
    Ihana-Sugiyama N, Yamamoto-Honda R, Sugiyama T, Tsujimoto T, Kakei M, Noda M.
    Med Sci Monit Basic Res; 2017 Feb 28; 23():36-44. PubMed ID: 28242866
    [Abstract] [Full Text] [Related]

  • 8. Effects of sitagliptin or mitiglinide as an add-on to acarbose on daily blood glucose fluctuations measured by 72 h subcutaneous continuous glucose monitoring in Japanese patients with type 2 diabetes: a prospective randomized study.
    Osonoi T, Saito M, Tamasawa A, Ishida H, Osonoi Y.
    Expert Opin Pharmacother; 2014 Jul 28; 15(10):1325-35. PubMed ID: 24866329
    [Abstract] [Full Text] [Related]

  • 9. Combination therapy with mitiglinide and voglibose improves glycemic control in type 2 diabetic patients on hemodialysis.
    Abe M, Okada K, Maruyama T, Maruyama N, Matsumoto K.
    Expert Opin Pharmacother; 2010 Feb 28; 11(2):169-76. PubMed ID: 20025554
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparing postprandial efficacy in type 2 diabetic patients receiving mitiglinide and sitagliptin by using continuous glucose monitoring: a pilot study.
    Ando K, Nishimura R, Seo C, Tsujino D, Sakamoto M, Utsunomiya K.
    Expert Opin Pharmacother; 2014 Dec 28; 15(17):2479-85. PubMed ID: 25327311
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA).
    Christensen AS, Hædersdal S, Støy J, Storgaard H, Kampmann U, Forman JL, Seghieri M, Holst JJ, Hansen T, Knop FK, Vilsbøll T.
    Diabetes Care; 2020 Sep 28; 43(9):2025-2033. PubMed ID: 32661107
    [Abstract] [Full Text] [Related]

  • 13. A comparative study of the effects of a dipeptidyl peptidase-IV inhibitor and sulfonylurea on glucose variability in patients with type 2 diabetes with inadequate glycemic control on metformin.
    Kim HS, Shin JA, Lee SH, Kim ES, Cho JH, Son HY, Yoon KH.
    Diabetes Technol Ther; 2013 Oct 28; 15(10):810-6. PubMed ID: 24050737
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of linagliptin monotherapy compared with voglibose on postprandial lipid profiles in Japanese patients with type 2 diabetes: linagliptin study of effects on postprandial blood glucose (L-STEP) sub-study 1.
    Kurozumi A, Okada Y, Satoh H, Inoue I, Chimori H, Akita E, Shiraiwa T, Fujitani Y, Mita T, Gosho M, Watada H.
    Endocr J; 2018 Apr 26; 65(4):415-425. PubMed ID: 29367471
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of Glycemic Excursion Using Flash Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus Before and After Treatment with Voglibose.
    Kasthuri S, Poongothai S, Anjana RM, Selvakumar J, Muthukumar S, Kayalvizhi S, Tariq S, Honey E, Gupta PK, Venkatesan U, Mohan V.
    Diabetes Technol Ther; 2021 Mar 26; 23(3):213-220. PubMed ID: 32916063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.